gabexate

This page covers all gabexate drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Coagulation factor XII, Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2.

Targets

Coagulation factor XII, Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2

Phase 3 pipeline (1)

• GABEXATE · Hematology
  GABEXATE works by inhibiting the activity of tryptase enzymes.

Patent intelligence

• gabexate patent landscape — aggregated cliff calendar, attackable patents, originator estates